SCOPUS 정보 검색 플랫폼

Human Psychopharmacology

Volumn 19, Issue 3, 2004, Pages 205-207

Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: A diagnostic challenge

(1) Gray, Nicola S a

a ALLEGHENY GENERAL HOSPITAL (United States)

Author keywords

Antipsychotic agents; Dopamine; Malignant syndrome; Neuroleptic; Parkinson's disease; Ziprasidone

Indexed keywords

ALPRAZOLAM; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBIDOPA PLUS LEVODOPA; CREATININE; DANTROLENE; IPRATROPIUM BROMIDE; LEVOTHYROXINE; LORAZEPAM; OLANZAPINE; PRAMIPEXOLE; QUETIAPINE; SALBUTAMOL; SERTRALINE; SIMVASTATIN; SODIUM CHLORIDE; ZIPRASIDONE;

ADULT; ANXIETY DISORDER; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE EXACERBATION; DRUG WITHDRAWAL; EDEMA; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HUMAN; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PARKINSONISM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOSIS; RESTLESSNESS;

ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSON DISEASE; PIPERAZINES; THIAZOLES;

EID: 1942488288 PISSN: 08856222 EISSN: None Source Type: Journal
DOI: 10.1002/hup.578 Document Type: Article

Times cited : (27)

References (15)

1
- 0028835745
- Serotonin syndrome
- Bodner RA, Lynch T, Lewis L. 1995. Serotonin syndrome. Neurology 45: 219-223.
- (1995) Neurology , vol.45 , pp. 219-223
- Bodner, R.A.¹ Lynch, T.² Lewis, L.³

2
- 0034127738
- The neuroleptic malignant and serotonin syndromes
- Carbone JR. 2000. The neuroleptic malignant and serotonin syndromes. Emerg Med Clin North Am 18: 317-325.
- (2000) Emerg. Med. Clin. North Am. , vol.18 , pp. 317-325
- Carbone, J.R.¹

3
- 0023877608
- Neuroleptic malignant syndrome
- Caroff SN, Mann SC. 1998. Neuroleptic malignant syndrome. Psychopharmacol Bull 24: 25-29.
- (1998) Psychopharmacol. Bull. , vol.24 , pp. 25-29
- Caroff, S.N.¹ Mann, S.C.²

4
- 0024550870
- Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome
- Castillo E, Rubin RT, Holsboer-Trachsler E. 1989. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry 146: 324-328.
- (1989) Am. J. Psychiatry , vol.146 , pp. 324-328
- Castillo, E.¹ Rubin, R.T.² Holsboer-Trachsler, E.³

5
- 0022406448
- On the early recognition of neuroleptic malignant syndrome
- Clark T, Ananth J, Dubin S. 1986. On the early recognition of neuroleptic malignant syndrome. Int J Psychiatr Med 15: 299-310.
- (1986) Int. J. Psychiatr. Med. , vol.15 , pp. 299-310
- Clark, T.¹ Ananth, J.² Dubin, S.³

6
- 84883833277
- Sur quelque erreurs de prescription des medicament psychiatrique
- Delay J, Deniker P. 1965. Sur quelque erreurs de prescription des medicament psychiatrique. Bull Mem Soc Med Hosp Paris 116: 487.
- (1965) Bull. Mem. Soc. Med. Hosp. Paris , vol.116 , pp. 487
- Delay, J.¹ Deniker, P.²

7
- 1942454542
- Neuroleptic malignant syndrome: Review, diagnostic critique
- Durrani KK. 2002. Neuroleptic malignant syndrome: review, diagnostic critique. Jefferson J Psychiatry 17: 11-31.
- (2002) Jefferson J. Psychiatry , vol.17 , pp. 11-31
- Durrani, K.K.¹

8
- 0035470411
- Neuroleptic malignant syndrome in advanced Parkinson's disease
- Gordon P, Frucht S. 2001. Neuroleptic malignant syndrome in advanced Parkinson's disease. Mov Disord 16: 960-962.
- (2001) Mov. Disord. , vol.16 , pp. 960-962
- Gordon, P.¹ Frucht, S.²

9
- 0141454226
- Neuroleptic malignant syndrome: Detection and management
- Lazarus A. 1985. Neuroleptic malignant syndrome: detection and management. Psychiatr Annals 15: 706-712.
- (1985) Psychiatr. Annals , vol.15 , pp. 706-712
- Lazarus, A.¹

10
- 0022370639
- Neuroleptic malignant syndrome
- Levenson JL. 1985. Neuroleptic malignant syndrome. Am J Psychiatry 142: 1137-1145.
- (1985) Am. J. Psychiatry , vol.142 , pp. 1137-1145
- Levenson, J.L.¹

11
- 0036897311
- Neuroleptic malignant syndrome with ziprasidone
- Murty RG, Mistry SG, Chacko RC. 2002. Neuroleptic malignant syndrome with ziprasidone. J Clin Psychopharmacol 22: 624-626.
- (2002) J. Clin. Psychopharmacol. , vol.22 , pp. 624-626
- Murty, R.G.¹ Mistry, S.G.² Chacko, R.C.³

12
- 0024314022
- Haloperidol induced neuroleptic malignant symdrome in a 67- year-old woman with parkinsonism
- Ryken TC, Merrell AN. 1989. Haloperidol induced neuroleptic malignant symdrome in a 67- year-old woman with parkinsonism. West J Med 151: 326-328.
- (1989) West J. Med. , vol.151 , pp. 326-328
- Ryken, T.C.¹ Merrell, A.N.²

13
- 0028875303
- Ziprasidone (CP-88 059): A new antipsychotic with combined dopamine and serotonin receptor antagonistic activity
- Seeger TF, Seymour PA, Schmidt AW, et al. 1995. Ziprasidone (CP-88 059): a new antipsychotic with combined dopamine and serotonin receptor antagonistic activity. J Pharmacol Exp Ther 275: 101-113.
- (1995) J. Pharmacol. Exp. Ther. , vol.275 , pp. 101-113
- Seeger, T.F.¹ Seymour, P.A.² Schmidt, A.W.³

14
- 0025869797
- The serotonin syndrome
- Sternbach H. 1991. The serotonin syndrome. Am J Psychiatry 148: 705-713.
- (1991) Am. J. Psychiatry , vol.148 , pp. 705-713
- Sternbach, H.¹

15
- 0033541088
- Susceptibility to neuroleptic malignant syndrome in Parkinsons disease
- Ueda M, Hamamoto M, Nagayama H, et al. 1999. Susceptibility to neuroleptic malignant syndrome in Parkinsons disease. Neurology 52: 777-781.
- (1999) Neurology , vol.52 , pp. 777-781
- Ueda, M.¹ Hamamoto, M.² Nagayama, H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.